Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-07-22
2011-12-13
Ewoldt, Gerald R (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S326000, C530S327000
Reexamination Certificate
active
08075899
ABSTRACT:
The present invention relates generally to the field of immunotherapy and immunodiagnosis of autoimmune conditions. More particularly, the present invention provides peptides of the A-chain of proinsulin or insulin, which are recognized by or are specific for proinsulin- or insulin-sensitized T-cells. The present invention further contemplates the use of the these agents in therapeutic and diagnostic applications for Type 1 diabetes.
REFERENCES:
patent: 5326559 (1994-07-01), Miller
patent: WO 02/074808 (2002-09-01), None
Skylar, J.S., et al Diabetes Care. 2003;28:1068-1076.
Dong, V.M., et al. Ped. Transplant. 1993;3:181-192.
Marketletter, Marketletter Pubs. (UK). Sep. 13, 1999.
Pozzilli, P., et al. Diabetol. 2000;43:1000-1004.
Goodnow, C.C. The Lancet. 2001;357:2115-2121.
Mannering, S.I., et al. Cli. Exp. Immunol. 2009;156:226-231.
Bell, J.J., et al. J. Immunol. 2008;180:1508-1516.
von Herrath, M. and Nepom, G.T. Nature Immunol. 2009;10(2):129-132.
Leslie, M. Science. 2009;327:1573.
van der Worp, H.B., et al. PLoS Med. 2010;7(3):1-8.
Haller, M.J., et al. Eur. J. Immunol. 2009;39:2054-2058.
Raju, R. et al. 1997 “T Cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: A study using HLA DQ8 and DQ6 transgenic mice”Human Immunol58:21-29.
Astill, T.P. et al. 2003 “Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and —protective HLA class II molecules”Diabetologia46:496-503.
Chang, S.-G. et al. 2003 “Role of disulfide bonds in the structure and activity of human insulin”Molecules and Cells16:323-330.
Hampl, J. et al. 1991 “Presentation of insulin and insulin A chain peptides to mouse T cells: involvement of cysteine residues”Molecular Immunology28:479-487.
Qiao, Z.-S. et al. 2001 “Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro”Biochemistry40:2662-2668.
Sieber, P. et al. 1978 “Synthesis and biological activity of two disulphide bond isomers of human insulin: [A7-A11, A6-B7-Cysteine]- and [A6-A7, A11-B7-Cystine]insulin (human)”Hoppe-Seyler's Z Physiol Chem359:113-123.
Williams, D.B. et al. 1993 “Characterization of the insulin A-chain major immunogenic determinant presented by MHC class II 1-Admolecules”J Immunol151:3627-3637.
Chang et al., “Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin.” (2003) Tissue Antigens, 62(5): 408-417.
Hua et al. “A protein caught in a kinetic trap: Structures and stabilities of insulin disulfide isomers.” (2002) Biochemistry, 41(50): 14700-14715.
Kent et al., “Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.” (2005) Nature, 435(7039): 224-228.
Mannering et al., “The insulin A-chain epitope recognised by human T-cells is post-translationally modified.” (2005) J Exp Med. 202(9):1191-7.
Harrison Leonard Charles
Mannering Stuart Ian
Purcell Anthony Wayne
Williamson Nicholas A.
Ewoldt Gerald R
Knobbe Martens Olson & Bear LLP
The Walter and Eliza Hall Institute of Medical Research
LandOfFree
Peptides of the A-chain of proinsulin or insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides of the A-chain of proinsulin or insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides of the A-chain of proinsulin or insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266832